“Do You Smoke?” Physician–Patient Conversations About Smoking and Lung Cancer

Marshall, Mary E; Shields, Cleveland G.; Alexander, Stewart C.

doi:10.1007/s13187-021-02067-2

Cited by 3 publications

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…30 However, recent studies have suggested that these discussions are not always implemented in a way that would address these feelings. 24,31 Patients with tobacco-related cancers may require proactive outreach to address depressive symptoms and stigma following a referral to programs such as TIPS. 15 Thus, the current study underscores the importance of asking and advising patients, particularly those diagnosed with a tobacco-related cancer, about recent tobacco use, as well as making direct referrals to evidence-based care and appropriate follow-up.…”

Section: Discussionmentioning

confidence: 99%

Demographic and Clinical Predictors of Engaging in Tobacco Cessation Counseling at a Comprehensive Cancer Center

Rodgers-Melnick

Zanotti

Lee

et al. 2022

JCO Oncology Practice

View full text Add to dashboard Cite

PURPOSE: To address challenges promoting tobacco cessation in oncology settings, it is important to understand characteristics associated with patient engagement in tobacco cessation treatment. This analysis examined predictors of participating in at least one tobacco cessation counseling session among patients referred to a comprehensive cancer center's Tobacco Intervention and Psychosocial Support (TIPS) service. METHODS: Patients with cancer who reported current smoking or recently quitting and referred to TIPS between June 2017 and February 2020 were included in the analysis. Independent variables included sex, race and ethnicity, insurance type, cancer diagnosis (tobacco-related or not), age, nicotine dependence, and cigarettes smoked per day at baseline. The outcome variable was completion of at least one tobacco cessation counseling session among those assessed by the TIPS program. Unadjusted and adjusted analyses tested associations between the independent variables and tobacco cessation counseling engagement. RESULTS: Of 360 oncology patients referred to the TIPS program, 224 (62.2%) were assessed and 120 (33%) engaged in at least one counseling session. After controlling for sociodemographics and tobacco use, the results demonstrated that patients diagnosed with tobacco-related cancers were 45.3% less likely to engage in the tobacco cessation program compared with those with non–tobacco-related cancers ( P = .041). CONCLUSION: Patients diagnosed with tobacco-related cancers were less likely to engage in TIPS. Additional therapeutic resources may be needed to engage these patients to address potential explanatory factors, such as stigma, guilt, and fatalism. More research is needed to explore the impact of a tobacco-related cancer diagnosis on treatment engagement.

show abstract

Section: Discussionmentioning

confidence: 99%

Demographic and Clinical Predictors of Engaging in Tobacco Cessation Counseling at a Comprehensive Cancer Center

Rodgers-Melnick

Zanotti

Lee

et al. 2022

JCO Oncology Practice

View full text Add to dashboard Cite

show abstract

Structural and spectral morphometry and diagnosis of lung tumors

Kong¹,

Wang²,

Guo³

et al. 2022

Infrared Physics & Technology

View full text Add to dashboard Cite

Global cancer stigma research: a U.S. National Cancer Institute workshop report

Heley,

Vanderpool,

Vedham

2024

JNCI Monographs

View full text Add to dashboard Cite

Stigma is a social process characterized by negative beliefs, attitudes, and stereotypes associated with a specific attribute or characteristic that leads to discrimination and social exclusion. Stigma manifests across the cancer control continuum and remains a key challenge for cancer prevention and control worldwide. In this commentary, we provide an overview of the U.S. National Cancer Institute’s (NCI) Global Cancer Stigma Research Workshop, a multi-disciplinary international conference held virtually in September 2022, which focused on the intersection of cancer and stigma. The meeting was unique in its convening of researchers, advocates, clinicians, and non-governmental and governmental organizations, who—as a collective—provided overarching topics, cross-cutting considerations, and future directions for the cancer stigma research community to consider, which we describe herein. In summary, studying cancer stigma comprehensively requires a holistic, adaptive, and multifaceted approach—and should consider interrelated factors and their intersection within diverse cultural and social contexts worldwide. Collectively, there was a call for: an inclusive approach, encouraging researchers and practitioners to identify and measure cancer stigma as a driver for cancer health inequities globally; an expansion of existing research methodology to include diversity of experiences, contexts, and perspectives; and collaborations among diverse stakeholders to develop more effective strategies for reducing stigma and improving cancer outcomes. Such efforts are essential to cultivating effective and equitable approaches to preventing and treating cancer worldwide.

show abstract

“Do You Smoke?” Physician–Patient Conversations About Smoking and Lung Cancer

Cited by 3 publications

References 24 publications

Demographic and Clinical Predictors of Engaging in Tobacco Cessation Counseling at a Comprehensive Cancer Center

Demographic and Clinical Predictors of Engaging in Tobacco Cessation Counseling at a Comprehensive Cancer Center

Structural and spectral morphometry and diagnosis of lung tumors

Global cancer stigma research: a U.S. National Cancer Institute workshop report

Contact Info

Product

Resources

About